* Histogen Inc HSTO.OQ reported a quarterly adjusted loss of 9
cents per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for a loss of 11
cents per share.
* Revenue was $591.00 thousand; analysts expected zero.
* The mean earnings estimate of analysts had risen by
about 45.2% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Histogen Inc shares had fallen by 7.7% this quarter and
lost 7.8% so far this year.
* The company reported a quarterly loss of $3.84 million.
* Wall Street's median 12-month price target for Histogen Inc is
$2.70
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated November 10 at 10:57 p.m.
All figures in US dollars unless otherwise stated